Learn how simplifying a bipolar disorder treatment regimen, with a single agent acting as the “foundation” and others added when needed, may both improve patient morale and be effective for symptom control.
The Journal of Clinical Psychiatry
Insights April 15, 2021
Polypharmacy and the Concept of a “Foundational Treatment” for Bipolar Disorder
J Clin Psychiatry 2020;81(4):OT19046AH1
Vol 87 • 2026 • Number 2
Read the Current Issue
Original Research
CBT following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention: The CBT-ENDURE Randomized Trial
Original Research
Neuropsychiatric Symptom Clusters and Brain Structure in Alzheimer’s Disease
Systematic Review
Thirty Years of the Diagnostic Criteria for Psychosomatic Research
Original Research
Efficacy of Olanzapine/Samidorphan on Negative Symptoms
Original Research
Comparing Risk Prediction for Suicide Attempts and Deaths After Emergency Department Visits
Clinical and Practical Psychopharmacology
